Abstract
The present article describes a successful novel therapeutic intervention with Aredia with one child with Rett syndrome, after suffering from six pathological fractures within less than 3 years due to severe osteoporosis. Since the initiation of the treatment (3 years ago), the child has not suffered any fractures. Patients with chronic diseases and those with disabilities or on anticonvulsant medications are at risk for low bone density and possibly for the resultant pathologic fractures that define osteoporosis in children. Individuals with Rett syndrome (RS) have been shown to have low bone mineral density (or osteopenia) at a young age. If osteoporosis occurs in a girl with RS, it can inflict pain and seriously impair the child’s mobility and quality of life. The present article describes a case study of a child with RS (showing an average of 1.75 fractures annually for the 4 years preceding the treatment) before and after a treatment with Aredia. Patient received 30 mg/day for 3 days on a once every 3-month cycle. There was a 45 % improvement in bone mass density (BMD) values from pre–post-intervention. The child had no fractures in the 3 years posttreatment. This finding is significant (p < 0.03). The BMD Z-scores of the child showed severe osteoporosis (Z-score of −3.8) at pre-intervention and are elevated to osteopenia levels (Z-score of −1.3) at post-intervention measurements. All measurements suggest that the treatment successfully reversed the osteoporotic process and prevented further fractures. This change caused great relief to the child and her family and an improvement in their quality of life. The findings support the ability (in one case) to reverse the progression of osteoporosis in individuals with Rett syndrome showing severe osteoporosis with multiple fractures.
This is a preview of subscription content, log in via an institution to check access.
References
Bianchi ML (2007) Osteoporosis in children and adolescents. Bone 41:486–495
Ward LM, Glorieux FH (2003) The spectrum of pediatric osteoporosis. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone: biology & diseases. Academic, San Diego, pp 401–442
Zacharin M (2004) Current advances in bone health of disabled children. Curr Opin Pediatr 16(5):545–551
Hartman C, Brik R, Tamir A, Merrick J, Shamir R (2004) Bone quantitative ultrasound and nutritional status in severely handicapped institutionalized children and adolescents. Clin Nutr 23(1):89–98
Gray B (1992) Fractures caused by falling from a wheelchair in patients with neuromuscular disease. Dev Med Child Neurol 34:589–592
Sahaf M (2005) Osteoporosis—the disease, diagnosis and management. (Hebrew), Shenbon. Relig Coll Educ 8:152–153
Kovanlikaya A, Loro M, Hantgartner T, Reynolds R, Roe T, Gilsanz V (1996) Osteopenia in children: CT assessment. Radiology 198:781–784
Henderson R (1997) Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 39:224–227
Loro M, Sayre J, Roe T, Goran M, Kaufman F, Gilsanz V (2000) Early identification of children predisposed to low peak bone mass and osteoporosis later in life. J Clin Endocrinol Metab 85:3908–3918
Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ (1997) Osteopenia in Rett syndrome. J Pediatr 131(5):771–774
Armstrong DD (1995) The neuropathology of Rett Syndrome overview 1994. Neuropediatrics 26:100–104
Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670–679
Lotan M, Merrick J (eds) (2001) Rett syndrome therapeutic interventions. Disability studies series. Nova Science, New York
Nieto MA, Candau RS, Prieto P (1995) Contribution to studies of seizures in Rett syndrome analysis of critical forms of four cases. Rev Neurol 23:1185–1189
Hunter K (1999) The Rett syndrome handbook. International Rett Syndrome Association, Washington DC
Heaney RP (2003) Advances in therapy for osteoporosis. Clin Med Res 1(2):93–99
Leonard H, Thomson M, Glasson E et al (1999) Metacarpophalangeal pattern profile and bone age in Rett syndrome: further radiological clues to the diagnosis. Am J Med Genet 12(83):88–95
Motil KJ, Schultz RJ, Abrams S et al (2006) Fractional calcium absorption is increased in girls with Rett syndrome. J Pediatr Gastroenterol Nutr 42(4):419–426
Budden SS, Gunness ME (2001) Bone histomorphometry in three females with Rett syndrome. Brain Dev 23(Suppl 1):S133–137
Hanks SB (2001) Why physical therapy? Rett Gaz Spring 1–2:4–6
Reid IR, Wattie DJ, Evans MC, Gamble GD, Stapleton JP, Cornish J (1994) Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis. J Clin Endocrinol Metab 79(6):1595–1599
Brunner R, Doderlein L (1996) Pathological fractures in patients with cerebral palsy. J Pediatr Orthop B 5:232–238
Acknowledgments
The authors would like to thank the child and her family for allowing us to use the medical documentation and information that led to the present article.
Conflicts of interest
The first author, on behalf of all authors, hereby declares that there is no conflict of interest that prevents us from participating in the present article and publishing the results.
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors contributed equally to the article.
Rights and permissions
About this article
Cite this article
Lotan, M., Reves-Siesel, R., Eliav-Shalev, R.S. et al. Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis. Osteoporos Int 24, 3059–3063 (2013). https://doi.org/10.1007/s00198-013-2423-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-013-2423-5